Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Overview of Psychodermatology

Kleinman, Amanda S. MD

Section Editor(s): Janicak, Philip G. MD, Editor

doi: 10.1097/01.IDT.0000392647.34560.2c
ARTICLE

Dr. Kleinman is Assistant Professor, Department of Psychiatry, Rush University Medical Center, 2150 West Harrison Street, Chicago, IL 60612; E-mail: amanda_kleinman@rush.edu.

All faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.

The author has disclosed that the use of doxepin, nortriptyline, pimozide, risperidone, olanzapine, clomipramine, haloperidol, lithium, hydroxyzine, gabapentin, carbamazepine, lamotrigine, mirtazapine, and/or amitriptyline for treatment of atopic dermatitis, urticaria, chronic Idiopathic pruritus, delusions of parasitosis, and/or trichotillomania as discussed in this article has not been approved by the U.S. Food and Drug Administration.

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article(s) and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 80% of the quiz questions correctly. This activity expires on December 31, 2011.

© 2011 by Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website